{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:16:13Z","timestamp":1788984973065,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hfc.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:16:06Z","timestamp":1785874566000},"page":"439-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patent Foramen Ovale in Patients with Neurologic Events"],"prefix":"10.1016","volume":"22","author":[{"given":"Yun Yun","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Viva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sperlongano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.hfc.2026.07.004_bib1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/jama.2025.10946","article-title":"Patent foramen ovale and stroke: a review","volume":"334","author":"Kent","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2026.07.004_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale (CLOSURE I)","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism (PC trial)","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke (CLOSE)","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke (Gore REDUCE)","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke (RESPECT extended follow-up)","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2026.07.004_bib8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2021.20956","article-title":"Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke (SCOPE)","volume":"326","author":"Kent","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2026.07.004_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke (RESPECT)","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.hfc.2026.07.004_bib10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.hfc.2026.07.004_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","article-title":"Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale\u2013associated stroke","volume":"77","author":"Tobis","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.hfc.2026.07.004_bib12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.122.041524","article-title":"Frequency and size of in situ thrombus within patent foramen ovale","volume":"54","author":"Yan","year":"2023","journal-title":"Stroke"},{"issue":"18","key":"10.1016\/j.hfc.2026.07.004_bib13","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2020.02.068","article-title":"Atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale","volume":"75","author":"Turc","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2026.07.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000506433","article-title":"Morphometric features of patent foramen ovale as a risk factor of cerebrovascular accidents: a systematic review and meta-analysis","volume":"49","author":"Ho\u0142da","year":"2020","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.004_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/23969873241247978","article-title":"European Stroke Organisation (ESO) guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke","volume":"9","author":"Caso","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.hfc.2026.07.004_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008356","article-title":"Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review, sequential meta-analysis, and new insights from CLOSE","volume":"7","author":"Turc","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.hfc.2026.07.004_bib17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.echo.2015.05.015","article-title":"Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of echocardiography and Society for cardiac angiography and interventions","volume":"28","author":"Silvestry","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2026.07.004_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent Foramen ovale in cryptogenic stroke (RoPE score)","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.hfc.2026.07.004_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/STROKEAHA.120.032453","article-title":"Embolic stroke of undetermined source and patent foramen ovale","volume":"52","author":"Strambo","year":"2021","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.004_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jamaneurol.2025.5446","article-title":"Patent foramen ovale closure in stroke and the PASCAL classification system","volume":"83","author":"Saver","year":"2026","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.hfc.2026.07.004_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209388","article-title":"Patent foramen ovale closure in older patients with stroke: patient selection for trial feasibility","volume":"102","author":"Wang","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.hfc.2026.07.004_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5853\/jos.2023.01599","article-title":"Cerebrovascular events in older patients with patent foramen ovale: current status and future perspectives","volume":"25","author":"Farjat-Pasos","year":"2023","journal-title":"J Stroke"},{"issue":"5","key":"10.1016\/j.hfc.2026.07.004_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/17474930251392333","article-title":"Outcomes of patent foramen ovale closure in patients over 60 years with cryptogenic stroke: a systematic review and meta-analysis","volume":"21","author":"Jazayeri","year":"2026","journal-title":"Int J Stroke"},{"key":"10.1016\/j.hfc.2026.07.004_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.rmed.2017.05.016","article-title":"The multiple dimensions of platypnea-orthodeoxia syndrome: a review","volume":"129","author":"Agrawal","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11886-024-02073-y","article-title":"Updates on patent foramen ovale (PFO) closure","volume":"26","author":"Voudris","year":"2024","journal-title":"Curr Cardiol Rep"},{"issue":"11","key":"10.1016\/j.hfc.2026.07.004_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","article-title":"Migraine intervention with STARFlex technology (MIST) trial","volume":"117","author":"Dowson","year":"2008","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.hfc.2026.07.004_bib27","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehw027","article-title":"Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial","volume":"37","author":"Mattle","year":"2016","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.hfc.2026.07.004_bib28","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","article-title":"Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial","volume":"70","author":"Tobis","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2026.07.004_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2020.11.068","article-title":"Pooled analysis of PFO occluder device trials in patients with PFO and migraine","volume":"77","author":"Mojadidi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2026.07.004_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6456272","article-title":"Patent foramen ovale closure for treating migraine: a meta-analysis","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Intervent Cardiol"},{"key":"10.1016\/j.hfc.2026.07.004_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/practneurol-2019-002450","article-title":"Patent foramen ovale","volume":"20","author":"Alakbarzade","year":"2020","journal-title":"Pract Neurol"},{"key":"10.1016\/j.hfc.2026.07.004_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or TIA: updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.hfc.2026.07.004_bib33","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","article-title":"Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"39","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2026.07.004_bib34","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline","volume":"362","author":"Kuijpers","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.004_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/17474930221124412","article-title":"Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke","volume":"18","author":"Diener","year":"2023","journal-title":"Int J Stroke"},{"key":"10.1016\/j.hfc.2026.07.004_bib36","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the AHA\/ASA","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"20","key":"10.1016\/j.hfc.2026.07.004_bib37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.0000000000009443","article-title":"Practice advisory update summary: patent foramen ovale and secondary stroke prevention","volume":"94","author":"Mess\u00e9","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.hfc.2026.07.004_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5853\/jos.2022.02103","article-title":"Establishment of the heart and brain team for patent foramen ovale closure in stroke patients: an expert opinion","volume":"24","author":"Kim","year":"2022","journal-title":"J Stroke"},{"issue":"21","key":"10.1016\/j.hfc.2026.07.004_bib39","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.3390\/jcm13216354","article-title":"Comparative effectiveness of devices for interventional patent foramen ovale closure: insights from a 23-Year monocentric analysis","volume":"13","author":"Kayvanpour","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hfc.2026.07.004_bib40","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1212\/WNL.0000000000005739","article-title":"Percutaneous patent foramen ovale closure for secondary stroke prevention: network meta-analysis","volume":"91","author":"Tsivgoulis","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.hfc.2026.07.004_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034249","article-title":"Atrial fibrillation after patent foramen ovale closure: incidence, pathophysiology, and management","volume":"13","author":"Apostolos","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"10.1016\/j.hfc.2026.07.004_bib42","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/heartjnl-2024-323905","article-title":"Persistence of residual shunt at 6 and 12 months after transoesophageal echocardiography-guided percutaneous closure of a patent foramen ovale for cryptogenic stroke","volume":"110","author":"Witte","year":"2024","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.hfc.2026.07.004_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209949","article-title":"Anticoagulation vs antiplatelets across subgroups of embolic stroke of undetermined source","volume":"103","author":"Ghannam","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.hfc.2026.07.004_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with PFO and cryptogenic stroke: systematic review and network meta-analysis","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.hfc.2026.07.004_bib45","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/STROKEAHA.120.030293","article-title":"Atrial fibrillation following patent foramen ovale closure: systematic review and meta-analysis","volume":"52","author":"Chen","year":"2021","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.hfc.2026.07.004_bib46","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jcin.2025.04.041","article-title":"15-Year outcomes of PFO closure in patients with cryptogenic embolism","volume":"18","author":"Gaspardone","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.hfc.2026.07.004_bib47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/17474930241298778","article-title":"Stroke recurrence after transcatheter PFO closure in patients with cryptogenic stroke","volume":"20","author":"Goessinger","year":"2025","journal-title":"Int J Stroke"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:54:33Z","timestamp":1788983673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713626000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1551713626000474"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2026.07.004","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patent Foramen Ovale in Patients with Neurologic Events","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}